Peptide lab documentation profile

PT-141 (Bremelanotide) Lab Documentation Notes

PT-141 (Bremelanotide) is listed for qualified in-vitro laboratory research. This note summarizes identity fields, batch documentation checks, and COA review points without providing product-use instructions or consumer-health claims.

Receptor ResearchCOA-focused notes

Important scope note: This peptide profile is limited to laboratory documentation context. It does not provide medical, legal, veterinary, dosing, preparation, injection, ingestion, administration, diagnosis, treatment, prevention, mitigation, compounding, or consumer health guidance.

Key documentation takeaways

  • Review PT-141 (Bremelanotide) by matching product name, size, and lot number to the batch-specific COA record.
  • Read identity, purity, quantity, method, and date fields together instead of treating any single value as a standalone claim.
  • Keep this page in documentation context only; it is not a protocol, preparation guide, dosing guide, or use recommendation.

Catalog identity fields

Product name: PT-141 (Bremelanotide)

Research category: Receptor Research

Catalog sizes: Standard

CAS/reference field: 189691-06-3

Molecular-weight field: 1025.18 g/mol

Purity field: ≥99%

Uploaded COA link is available in the COA catalog for the current published batch record.

Batch record review

For PT-141 (Bremelanotide), review the product label, size, lot number, and COA as a single batch record. If the fulfilled lot differs from a previously uploaded document, use the documentation provided with that fulfilled order.

Analytical terms on the COA should be read in context with the issuing lab, test date, identity field, purity field, and method language. This profile does not convert those records into medical, body-effect, or consumer-use claims.

Product description for catalog context: PT-141 is listed for qualified laboratory research involving melanocortin receptor reference workflows and batch-specific analytical documentation.

COA links